Feagan BG - Search Results

1

Controversies in Inflammatory Bowel Disease: Exploring Clinical Dilemmas Using Cochrane Reviews.

East JE, Boyapati RK, Torres J, Parker CE, MacDonald JK, Chande N, Feagan BG. East JE, et al. Among authors: feagan bg. Inflamm Bowel Dis. 2019 Feb 21;25(3):472-478. doi: 10.1093/ibd/izy268. Inflamm Bowel Dis. 2019. PMID: 30789982 Review.

2

Maintenance therapy for inflammatory bowel disease.

Feagan BG. Feagan BG. Am J Gastroenterol. 2003 Dec;98(12 Suppl):S6-S17. doi: 10.1016/j.amjgastroenterol.2003.11.002. Am J Gastroenterol. 2003. PMID: 14697913 Review.

3

A cluster-randomized controlled trial of a blood conservation algorithm in patients undergoing total hip joint arthroplasty.

Wong CJ, Vandervoort MK, Vandervoort SL, Donner A, Zou G, MacDonald JK, Freedman J, Karkouti K, MacDonald SJ, Feagan BG. Wong CJ, et al. Among authors: feagan bg. Transfusion. 2007 May;47(5):832-41. doi: 10.1111/j.1537-2995.2007.01197.x. Transfusion. 2007. PMID: 17465948 Clinical Trial.

4

Introduction to Cochrane systematic reviews.

Feagan BG, McDonald JW, Chande N, MacDonald JK. Feagan BG, et al. Inflamm Bowel Dis. 2011 Jan;17(1):334-5. doi: 10.1002/ibd.21372. Inflamm Bowel Dis. 2011. PMID: 20848548 No abstract available.

5

Therapeutic drug monitoring of biologics for inflammatory bowel disease.

Colombel JF, Feagan BG, Sandborn WJ, Van Assche G, Robinson AM. Colombel JF, et al. Among authors: feagan bg. Inflamm Bowel Dis. 2012 Feb;18(2):349-58. doi: 10.1002/ibd.21831. Epub 2011 Oct 21. Inflamm Bowel Dis. 2012. PMID: 22021134 Review.

6

Recommendations for the treatment of Crohn's disease with tumor necrosis factor antagonists: an expert consensus report.

Feagan BG, Lémann M, Befrits R, Connell W, D'Haens G, Ghosh S, Michetti P, Ochsenkühn T, Panaccione R, Schreiber S, Silverberg M, Sorrentino D, van der Woude CJ, Vermeire S, Rutgeerts P. Feagan BG, et al. Inflamm Bowel Dis. 2012 Jan;18(1):152-60. doi: 10.1002/ibd.21870. Epub 2011 Oct 29. Inflamm Bowel Dis. 2012. PMID: 22038857

7

Once daily oral mesalamine compared to conventional dosing for induction and maintenance of remission in ulcerative colitis: a systematic review and meta-analysis.

Feagan BG, MacDonald JK. Feagan BG, et al. Inflamm Bowel Dis. 2012 Sep;18(9):1785-94. doi: 10.1002/ibd.23024. Epub 2012 May 29. Inflamm Bowel Dis. 2012. PMID: 22644954

8

Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.

Feagan BG, Macdonald JK. Feagan BG, et al. Cochrane Database Syst Rev. 2012 Oct 17;10:CD000543. doi: 10.1002/14651858.CD000543.pub3. Cochrane Database Syst Rev. 2012. Update in: Cochrane Database Syst Rev. 2016 Apr 21;4:CD000543. doi: 10.1002/14651858.CD000543.pub4 PMID: 23076889 Updated. Review.

9

Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.

Feagan BG, Macdonald JK. Feagan BG, et al. Cochrane Database Syst Rev. 2012 Oct 17;10:CD000544. doi: 10.1002/14651858.CD000544.pub3. Cochrane Database Syst Rev. 2012. Update in: Cochrane Database Syst Rev. 2016 May 09;(5):CD000544. doi: 10.1002/14651858.CD000544.pub4 PMID: 23076890 Updated. Review.

10

Methotrexate for induction of remission in refractory Crohn's disease.

McDonald JW, Tsoulis DJ, Macdonald JK, Feagan BG. McDonald JW, et al. Among authors: feagan bg. Cochrane Database Syst Rev. 2012 Dec 12;12:CD003459. doi: 10.1002/14651858.CD003459.pub3. Cochrane Database Syst Rev. 2012. Update in: Cochrane Database Syst Rev. 2014 Aug 06;(8):CD003459. doi: 10.1002/14651858.CD003459.pub4 PMID: 23235598 Updated. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

520 results

Search Page

Filters